QR Code

Modeling lung adenocarcinoma metastases using patient-derived organoids

Summary: Approximately 50% of patients with surgically resected early-stage lung cancer develop distant metastasis. At present, there is no in vivo metastasis model to investigate the biology of human lung cancer metastases. Using well-characterized lung adenocarcinoma (LUAD) patient-derived organoi...

Full description

Saved in:
Main Authors: Yuan Liu, Manendra Lankadasari, Joel Rosiene, Kofi E. Johnson, Juan Zhou, Samhita Bapat, Lai-Fong L. Chow-Tsang, Huasong Tian, Brooke Mastrogiacomo, Di He, James G. Connolly, Harry B. Lengel, Raul Caso, Elizabeth G. Dunne, Cameron N. Fick, Gaetano Rocco, Smita Sihag, James M. Isbell, Mathew J. Bott, Bob T. Li, Piro Lito, Cameron W. Brennan, Mark H. Bilsky, Natasha Rekhtman, Prasad S. Adusumilli, Marty W. Mayo, Marcin Imielinski, David R. Jones
Format: Artigo
Language:Inglês
Published: Elsevier 2024-10-01
Series:Cell Reports Medicine
Subjects:
patient-derived organoids
lung adenocarcinoma
in vivo LUAD metastasis
tumor evolution
metastasis marker
drug resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S2666379124005226
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items